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Background: Non-typhoidal Salmonella is a common cause of infectious diarrhea in humans. Antimicrobial-resistant
Salmonella has become a global concern.
Methods: Using laboratory-based surveillance system for Salmonella from September 2009 to December 2012 in
Guangdong Province of China. The clinical information and samples of diarrhea patients were collected, according
to the surveillance case definition. The lab tests were followed by standardized protocols, including sample isolation,
isolates confirmation, serotyping, and antimicrobial susceptibility testing (AST).
Results: A total of 1,826 Salmonella isolates were identified from40,572 patients in 28 hospitals in11 prefectures. The
isolates ratio was highest in autumn (38.8%, 708/1826) and lowest in winter (6.4%, 117/1826). Children aged <5 years
were the group most affected by Salmonella in Guangdong Province accounting for 73% (1,329/1,826), of whom the
infants (<1 year) were 81.5% (1084/1329) especially. A total of 108 serotypes were identified among the isolates. S.
Typhimurium represented the most common serotype followed by serotype 4,5,12:i:-.
S. Typhimurium was also the common serotype followed by S. Enteritidis among infants and children aged 1-3
years old. However, S. Enteritidis became the common serotype followed by S. Typhimurium among children
aged 3–5 and >5 years.
Resistance to at least one antimicrobial was found in 72% (1321/1,826) of the isolates. Resistance to at least three
antimicrobials was found in 46% (850/1,826) of the isolates. Resistance to all 12 antimicrobials screened was
observed in 8 isolates (0.44%, 8/1,826). The resistant prevalence to quinolones including nalidixic acid and
ciprofloxacin was 61.9% (1131/1826), of which ciprofloxacin resistance rate was 8.05% (147/1826). The prevalence
resistance to all three cephalosporin antimicrobials (cefepime, cefotaxime, and caftazidime) in <5 yr age group
was accounted for 90% (89/99).
Conclusions: Additional data and more refined methods can improve future surveillance. The invasive Salmonella
isolates should also be included to the antibiotic resistance surveillance for clinical care or public health.* Correspondence: Dengxiaolinggd@aliyun.com
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Foodborne disease is a global public health problem.
Non-typhoidal Salmonella (NTS) remains one of the
most commonly reported bacterial causes of foodborne
infections diseases [1]. It is well-recognized that salmon-
ellosis can be acquired by consumption of contaminated
water, meat, eggs, or milk, or by contact with infected
food animals and patients [2]. Manifestations of NTS in-
cluded diarrheal and septicemia. Estimates suggest that
globally 93.8 million people are infected by NTS, with
155,000 deaths each year [3]. In the United States, NTSis
estimated to cause 1,027,561 illnesses, 19,336 hospitali-
zations and 378 deaths annually [4]. It has also been
shown that children aged <5 years are a susceptible
population to Salmonella infection [5]. However, similar
data with respect to NTS infections is lacking in China
[6]. NTS is typically self-limiting; antimicrobials are gener-
ally reserved for invasive infections [7]. Fluoroquinolones
are among the antimicrobials commonly used to treat in-
vasive salmonellosis among adults while cephalosporins
are often employed for children [8,9]. However, several
studies have shown a decreased susceptibility to cipro-
floxacin as well as cephalosporins in Salmonella [9-12].
Furthermore, fluoroquinolone treatment failure in
Salmonella infection has been reported in some coun-
tries [13-15]. Antimicrobial -resistant Salmonella has
become a global concern [16,17].
Currently, the national notifiable infectious diseases
reporting system required diarrhea case reporting based
on symptoms only. Laboratory-based surveillance is not
commonly conducted at this time in China [18]. How-
ever, laboratory-based surveillance can provide informa-
tion that permits identification of risk factors and
control of infectious diseases, and implementation of
NTS surveillance will allow for investigation of charac-
teristics of Salmonella infections. Guangdong Province
is a subtropical area in south China, with a season of
high temperatures and humidity from March to
October. Since 2009, laboratory-based surveillance for
NTS has been established by the Guangdong Center for
Disease Control and Prevention (GDCDC) [19]. In this
report,epidemiological characteristics,including seasonal
tendency, age distribution associated with serotype di-
versity, and antimicrobial resistance of NTS infections in
Guangdong province are presented.
Methods
Study design
The surveillance case definition was defined as a person
who presented with three or more loose stools within
24 hours and whose diarrhea was associated with one or
more of the following symptoms:fever, vomiting, or ab-
dominal pain. Data from September 2009 to December
2012 collected from 28 hospitals in 11 prefectures inGuangdong Province were included in this analysis.
Among the 28 hospitals, five were pediatric facilities and
the remaining were general hospitals. Epidemiologic in-
formation about the patients such as sex, age and con-
sult date were recorded. Spring was defined from March
to May, summer from June to August, autumn from
September to November, winter from December to
February. A standardized protocol was distributed to the
sentinel hospitals to guide the collection and processing
of stool samples. Clinical laboratories were responsible
for Salmonella isolation and suspected isolates were
stored in semi-solid agar and submitted to GDCDC
within one week of collection for confirmation, serotyp-
ing, and Antimicrobial susceptibility testing.
The research involving human subjects have been ap-
proved with Guangdong medical ethics comply with the
Helsinki Declaration. All the participants have approved
the study.
Salmonella serotyping
NTS isolates were confirmed using API 20E test strips
(bioMerieux, Marcy L’Etoile, France) before serotyping. O
and H antigens were characterized using commercial anti-
serum (S&A Reagents Lab, Bangkok, Thailand) and the se-
rotypes were identified according to Kauffmann-White
Scheme [20].
Antimicrobial susceptibility testing (AST)
The antimicrobial susceptibility of the isolates was deter-
mined according to the guidelines of the Clinical and
Laboratory Standards Institute (CLSI) [21]. Disk diffu-
sion assays were performed on Muller-Hinton agar with
antibiotic impregnated disks. The tested antibiotics in-
cluded streptomycin 10 μg (S), gentamicin 10 μg (G),
ceftazidime 30 μg (Caz), cefotaxime 30 μg (Ctx), cefe-
pime 30 μg (Fep), ampicillin 10 μg (A), nalidixic acid
30 μg (Nal), ciproflaxin 5 μg (Cp), tetracycline 30 μg (T),
chloramphenicol 30 μg (C), sulfamethoxazole 300 μg (Su),
and trimethoprim 5 μg (Tm). The diameter of the inhib-
ition zone was interpreted as resistant, intermediate or
susceptible according to CLSI guidelines [21]. Escherichia
coli ATCC 25922 was used as quality control organism.
Ampicillin, trimethoprim, sulfamethoxazole, cefotaxime,
ceftazidime, cefpime, ciprofloxacin and gentamicin were
defined as clinically important antimicrobials [22]. Multi-
drug resistance (MDR) was identified as resistance to three
or more than three classes of antimicrobials. ACSSuT
pattern was defined as resistance to ampicillin, chloram-
phenicol [6]. Streptomycin, sulfamethoxazole, tetracycline.
Data analysis
Data were analyzed using SPSS version 13.0 (SPSS
Institute, city, state, USA). Chi-squared analysis was per-
formed to test the statistical association between
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centage of multi-drug resistant isolates in a given serotype.
A P-value <0.05 was considered statistically significant.Results
Isolation rate and serotypes
Stool samples were collected from 40,572 patients with
diarrhea in Guangdong Province between September 2009
and December 2012, and1,826 NTS isolates were recov-
ered. The isolation rate of NTS was 4.5%. A total of 108 se-
rotypes were identified among the isolates. Ten serotypes
accounted for 80% (1,462/1,826) of the NTS isolates in this
study, including S. Typhimurium (n = 550; 30%), S. sero-
type 4,5,12:i:- (n = 254; 14%), S. Enteritidis (n = 245; 13%),
S. Stanley (n = 189; 10%), S. Derby (n = 48; 2.6%), S. Rissen
(n = 43; 2.4%), S. Weltevreden (n = 38; 2.1%), S. Infantis
(n = 29; 1.6%), S. Thompson (n = 26; 1.4%), S. Albany
(n = 20; 1.1%) and S. Agona (n = 20; 1.1%).Seasonal, sex and age distribution
The isolation rate in spring was 3.5% (261/7,488), 6.4%
(680/10594) in summer, 5.4% (708/13,039) in autumn
and 1.9% (177/9,451) in winter. The isolation rate was
highest in September 2011 (10%, 83/817) and lowest in
December, 2009 (0.8%, 7/861). Infections occurring in
autumn accounted for 39% of all NTS cases followed
by 37% in summer.Table 1 Descriptive data of Salmonella infections by serotype
Variable Typhimurium 4,5,12:i:- Enteritidis Stanley Derby Rissen
N (%) N (%) N (%) N (%) N (%) N (%)
Season
Spring 100 (38) 35 (13) 41 (16) 23 (8.8) 6 (2.3) 4 (1.5)
Summer 184 (27) 111 (16) 88 (13) 59 (8.7) 23 (3.4) 23 (3.4)
Autumn 213 (30) 87 (12) 88 (12) 96 (14) 14 (2.0) 13 (1.8)
Winter 53 (30) 21 (12) 28 (16) 11 (6.2) 5 (2.8) 3 (1.7)
Sex
Male 324 (31) 151 (15) 125 (12) 102 (10) 27 (2.6) 24 (2.3)
Female 200 (28) 98 (14) 109 (15) 81 (11) 20 (2.8) 16 (2.2)
Unknown 26 (37) 5 (7.1) 11 (16) 6 (8.6) 1 (1.4) 3 (4.3)
Age
≤1 404 (37) 189 (17) 74 (6.8) 120 (11) 24 (2.2) 26 (2.4)
~2 41 (21) 32 (17) 34 (18) 35 (18) 5 (2.6) 2 (1.0)
~3 24 (28) 10 (9.1) 24 (22) 7 (6.4) 4 (3.6) 1 (0.9)
~4) 12 (17) 3 (4.3) 22 (32) 6 (8.7) 1 (1.4) 1 (1.4)
~5 9 (19) 4 (8.5) 18 (38) 2 (4.3) 1 (2.1) 0 (0.0)
≥5 20 (9.6) 7 (3.3) 54 (26) 11 (5.3) 10 (4.8) 9 (4.3)
Unknown 40 (35) 9 (7.8) 19 (16) 8 (7.0) 3 (2.6) 4 (3.5)
Overall 550 (30) 254 (14) 245 (13) 189 (10) 48 (2.6) 43 (2.4)There were 1,031 males and 725 females infected with
NTS; the sex of 70 cases was unknown. The overall
male/female ratio was 1.4:1. The patients ranged in age
from 20 days to 96 years (115 cases unknown). The me-
dian age was 1 year. Children <5 years accounted for73%
(1,329/1,826) of NTS cases. Of the 1,329 patients,1,084
were infants <1 year. Among infants, S. Typhimurium
was the most common serotype causing 37% (404/
1,084) of infections followed by S. serotype 4,5,12:i:-
(17%, 189/1,084) and S. Stanley (11%, 120/1084). S.
Enteritidis accounted for only 6.8% (74/1,084). Among
children aged1-2 and 2–3 years, S. Typhimurium was
the highest, followed by S. Enteritidis, S. serotype
4,5,12:i:- and S. Stanley. However, among children
aged 3–4, 4–5, and >5 years, the proportion infected
with S. Enteritidis became the highest compared to
other serotypes, and S. Typhimurium became the sec-
ond common serotype (Table 1).
Antimicrobial resistance
A total of 168 (9.2%) of the 1,826 NTS isolates were suscep-
tible to all 12 antimicrobials (9.2%). S. Weltevreden showed
a high rate of pan-susceptibility to antimicrobials (47%, 18/
38), followed by S. Stanley (31%, 58/189). However, very
few S. Typhimurium (1.5%; 8/550) and S. serotype 4,5,12:i:-
(0.8%,2/254) isolates were pan-susceptible. The Salmonella
isolates obtained in this study showed high prevalence of
resistance to the tested antimicrobials (Table 2). Overallin diarrhea patients in Guangdong province in 2009 – 2012
Weltevreden Infantis Thompson Albany Agona Other Overall
N (%) N (%) N (%) N (%) N (%) N (%) N (%)
7 (2.7) 0 (0.0) 6 (2.3) 1 (0.4) 2 (0.8) 36 (14) 261 (100)
10 (1.5) 10 (1.5) 5 (0.7) 10 (1.5) 12 (1.8) 145 (21) 680 (100)
14 (2.0) 18 (2.5) 11 (1.6) 9 (1.3) 5 (0.7) 140 (20) 708 (100)
7 (4.0) 1 (0.6) 4 (2.3) 0 (0.0) 1 (0.6) 43 (24) 117 (100)
25 (2.4) 16 (1.6) 15 (1.5) 8 (0.8) 12 (1.2) 202 (20) 1031 (100)
12 (1.7) 11 (1.5) 8 (1.1) 12 (1.7) 8 (1.1) 150 (21) 725 (100)
1 (1.4) 2 (2.9) 3 (4.3) 0 (0.0) 0 (0.0) 12 (17) 70 (100)
13 (1.2) 18 (1.7) 13 (1.2) 10 (0.9) 10 (0.9) 183 (17) 1084 (100)
0 (0.0) 2 (1.0) 5 (2.6) 3 (1.6) 4 (2.1) 29 (15) 192 (100)
7 (6.4) 3 (2.7) 1 (0.9) 0 (0.0) 2 (1.8) 27 (24) 110 (100)
4 (5.8) 0 (0.0) 2 (2.9) 3 (4.3) 1 (1.4) 14 (20) 69 (100)
1 (2.1) 1 (2.1) 0 (0.0) 1 (2.1) 0 (0.0) 10 (21) 47 (100)
12 (5.7) 3 (1.4) 2 (1.0) 3 (1.4) 3 (1.4) 75 (36) 209 (100)
1 (0.9) 2 (1.7) 3 (2.6) 0 (0.0) 0 (0.0) 26 (23) 115 (100)
38 (2.1) 29 (1.6) 26 (1.4) 20 (1.1) 20 (1.1) 364 (20) 1826 (100)
Table 2 Antimicrobial resistance of Salmonella serotypes in Guangdong province in 2009 - 2012
Antimicrobial Typhimurium (n = 550) 4,5,12:i:- (n = 254) Enteritidis (n = 245) Stanley (n = 189) Derby (n = 48) Rissen (n = 43)
<5 yrs ≥5 yrs <5 yrs ≥5 yrs <5 yrs ≥5 yrs <5 yrs ≥5 yrs <5 yrs ≥5 yrs <5 yrs ≥5 yrs
N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%)
Aminoglycosides
Getamicin 302 (66) 32 (65) 131 (57) 10 (71) 14 (12) 13 (12) 11 (6.9) 1 (4.8) 8 (27) 6 (40) 3 (11) 3 (27)
Streptomycin 335 (73) 36 (74) 154 (67) 9 (64) 44 (36) 41 (39) 22 (14) 1 (4.8) 10 (33) 7 (47) 13 (46) 6 (54)
Cephalosporins
Cefepime 71 (15) 3 (6.1) 29 (13) 1 (7.1) 14 (12) 6 (5.7) 9 (5.6) 0 (0.0) 3 (10) 0 (0.0) 5 (18) 0 (0.0)
Cefotaxime 67 (14) 5 (10) 30 (13) 0 (0.0) 12 (10) 5 (4.8) 10 (6.3) 1 (4.8) 3 (10) 0 (0.0) 5 (18) 0 (0.0)
Caftazidime 45 (9.8) 2 (4.1) 18 (7.8) 0 (0.0) 7 (5.8) 5 (4.8) 8 (5.0) 1 (4.8) 1 (3.3) 0 (0.0) 3 (11) 0 (0.0)
Penicillins
Ampicillin 412 (89) 35 (71) 215 (93) 11 (79) 68 (56) 59 (56) 18 (11) 3 (14) 12 (40) 6 (40) 21 (75) 8 (73)
Quinolones
Nalidixic acid 383 (83) 37 (76) 167 (73) 13 (93) 94 (78) 89 (85) 17 (11) 1 (4.8) 11 (37) 7 (47) 3 (11) 1 (9.1)
Ciprofloxacin 56 (12) 5 (10) 27 (12) 1 (7.1) 7 (5.8) 7 (6.7) 8 (5.0) 0 (0.0) 1 (3.3) 3 (20) 1 (3.6) 0 (0.0)
Tetracyclines
Tetracycline 402 (87) 34 (69) 214 (93) 13 (93) 32 (26) 28 (27) 22 (14) 1 (4.8) 21 (70) 8 (53) 25 (89) 8 (73)
Amphenicols
Chloramphenicol 335 (73) 28 (57) 154 (67) 9 (64) 5 (4.1) 5 (4.8) 8 (5.0) 2 (9.5) 9 (30) 6 (40) 4 (14) 1 (9.1)
Sulfonamides
Sulfamethoxazole 398 (86) 35 (71) 206 (89) 12 (86) 60 (50) 53 (50) 31 (19) 3 (14) 15 (50) 7 (47) 21 (75) 5 (46)
Trimethoprim 298 (65) 27 (55) 117 (51) 8 (57) 16 (13) 10 (9.5) 10 (6.3) 2 (9.5) 8 (27) 6 (40) 24 (86) 9 (82)
Multi-resistance
≥3 antimicrobials 356 (77) 31 (63) 188 (81) 9 (64) 65 (54) 73 (70) 49 (31) 7 (33) 15 (50) 6 (40) 22 (79) 8 (73)

























<5 yrs ≥5 yrs <5 yrs ≥5 yrs <5 yrs ≥5 yrs <5 yrs ≥5 yrs <5 yrs ≥5 yrs <5 yrs ≥5 yrs
N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%)
Aminoglycosides
Getamicin 3 (23) 1 (4.2) 2 (10) 2 (29) 2 (10) 1 (25) 3 (27) 1 (11) 4 (29) 1 (17) 37 (17) 19 (16)
Streptomycin 3 (23) 3 (12) 2 (10) 2 (29) 12 (63) 3 (75) 3 (27) 3 (33) 4 (29) 2 (33) 61 (28) 37 (32)
Cephalosporins













Table 2 Antimicrobial resistance of Salmonella serotypes in Guangdong province in 2009 - 2012 (Continued)
Cefotaxime 2 (15) 0 (0.0) 3 (15) 0 (0.0) 5 (26) 1 (25) 4 (36) 0 (0.0) 2 (14) 0 (0.0) 0 (0.0) 9 (7.7)
Caftazidime 2 (15) 0 (0.0) 2 (10) 0 (0.0) 6 (32) 1 (25) 3 (27) 0 (0.0) 2 (14) 1 (17) 16 (7.2) 7 (6.0)
Penicillins
Ampicillin 1 (7.7) 2 (8.3) 16 (80) 6 (86) 12 (63) 1 (25) 11 (100) 9 (100) 3 (21) 2 (33) 79 (36) 33 (28)
Quinolones
Nalidixic acid 2 (15) 2 (8.3) 16 (80) 5 (71) 5 (26) 2 (50) 9 (82) 9 (100) 4 (29) 0 (0.0) 71 (32) 36 (31)
Ciprofloxacin 0 (0.0) 1 (4.2) 0 (0.0) 0 (0.0) 0 (0.0) 2 (50) 1 (9.1) 0 (0.0) 3 (21) 1 (17) 19 (8.6) 4 (3.4)
Tetracyclines
Tetracycline 2 (15) 4 (17) 11 (55) 6 (86) 13 (68) 2 (50) 9 (82) 9 (100) 6 (43) 2 (33) 82 (37) 52 (44)
Amphenicols
Chloramphenicol 0 (0.0) 2 (8.3) 12 (60) 6 (86) 7 (37) 2 (50) 9 (82) 9 (100) 3 (21) 2 (33) 45 (20) 16 (14)
Sulfonamides
Sulfamethoxazole 3 (23) 5 (21) 15 (75) 6 (86) 14 (74) 2 (50) 10 (91) 9 (100) 3 (21) 1 (17) 79 (36) 50 (43)
Trimethoprim 1 (7.7) 3 (12) 13 (65) 4 (57) 8 (42) 2 (50) 9 (82) 9 (100) 2 (14) 1 (17) 51 (23) 37 (32)
Multi-resistance
≥3 antimicrobials 4 (31) 12 (50) 13 (65) 3 (43) 16 (84) 4 (100) 9 (82) 8 (89) 5 (36) 4 (67) 106 (48) 62 (53)
ACSSuT* 0 (0.0) 0 (0.0) 1 (5.0) 2 (29) 6 (32) 1 (25) 3 (27) 3 (33) 1 (7.1) 1 (17) 25 (11) 12 (10)
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prevalence of antimicrobial resistance than those from pa-
tients >5 years, and included resistance to cephalosporins
and quinolones.
Resistance to cefepime, cefotaxime, and ceftazidime
was found in 10%, 11%, and 7.4% of isolates, respect-
ively. Resistance to all three cephalosporin antimicrobials
was seen in 99 isolates, of which patients <5 years
accounted for 90% (89/99) and S. Typhimurium
accounted for 46% (45/99). Among children <5 years,
isolates resistant to cefepime, cefotaxime and caftazidime
accounted for 12%, 12%and 8.5% while the resistance
rate in patients ≥5 years was 4.7%, 5.5%, and 4.5%,
respectively. The resistance rate to cefepime (P < 0.01)
and cefotaxime (P < 0.01) was higher in children <5 years
than in patients >5 years but no difference was seen in
the resistance rate to ceftazidime (P > 0.05).
A high prevalence of nalidixic acid resistance was ob-
served (58%; 1,062/1,826) in the NTS isolates. A total
of 155 isolates (8.5%, 155/1826) were resistant to cipro-
floxacin. The overall resistance rate to ciprofloxacin in-
creased from 2.4% in 2009 to 12% in 2012 (Figure 1). S.
Typhimurium, S. serotype 4,5,12:i:- and S. Enteritidis
accounted for 843 out of the 1,062 resistant isolates (79%).
Isolates of S. Typhimurium made up 41% (64/155) of the

































Figure 1 Antimicrobial resistance rate of different antimicrobial agenA rate of 63% (1156/1826) MDR was observed in NTS
isolates in this study, with S. Typhimurium isolates ac-
counting for 36% (418/1156) followed by S. serotype
4,5,12:i:- (18%, 206/1156) and S. Enteritidis (13%, 150/
1156). Resistance to at least one antimicrobial was found
in 72% (1321/1,826) of the isolates; resistance to at least
three antimicrobials was found in 46% (850/1,826) of the
isolates. Resistance to all 12 antimicrobials screened as part
of this surveillance project was observed in 8 isolates (6 S.
Typhimurium, a single S. serotype 4,5,12:i:- and a single
Duisburg). In this study, 473NTS isolates showed the ACS-
SuT resistance pattern. S. Typhimurium accounted for 60%
(284/473) followed by S. serotype 4,5,12:i:- (21%, 101/473).
This resistance pattern was significantly associated with
infection by S. Typhimurium and S. serotype 4,5,12:i:-com-
pared to other serotypes (P< 0.01). Childrenaged < 5 years
accounted for 27% (412/1,502) of NTS isolates with the
ACSSuT pattern, while there were only 16% (33/209)
patients aged ≥5 yearshad this pattern (P< 0.01).
Discussion
In this study, we report epidemiologic characteristics of
NTS infections in Guangdong Province from 2009 to
2012. An increase in the NTS isolation rate was ob-
served beginning at 3.4% in 2009, 3.5% in 2010, 4.4% in
2011 and 5.1% in 2012. Since the surveillance was con-
ducted, several training courses were designed byMP NAL CIP TCY CHL SMX TMP
timicrobials
2011 2012
ts inNon-typhoidal Salmonella in Guangdong, 2009–2012.
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acity of detecting and reporting food-borne disease cases
in Guangdong Province [23].
Our study showed that children aged <5 years were
the group most affected by NTS in Guangdong Province.
In a previous study, children <5 years were shown to be
at risk for NTS infections [24]. In the United States, the
NTS isolation rate was highest in patients aged < 1 year
[25]. In our study, children aged <5 years accounted for
73% of the overall NTS infections. Even in general hos-
pitals, children <5 years accounted for 65% of the infec-
tions. This rateis were higher than that in a previous
national report, which NTS isolated from eight provinces
were associated with diarrhea in 34% of patients < 5 years
in China [6]. In other countries, a high prevalence of
NTS infection in children < 5 years has also been re-
ported [26,27]. Future epidemiological investigations
about risk factors should be conducted to determine
why children <5 years, especially infants (<1 year) in
Guangdong have become the majority of infections for
disease control and prevention.
Salmonella serotype 4,5,12:i:- is considered a mono-
phasic variant of serotype Typhimurium with similar
antigenic and genotypic characteristics. In our study, the
percentage of S. serotype 4,5,12:i:- increased from 3.6%
in 2009 to 20% in 2011 and down to 15% in 2012, be-
coming one of the most common Salmonella serotypes
in Guangdong. In Europe,S. serotype 4,5,12:i:-showed a
marked increase in foodborne infections with an associ-
ation in pig meat [28]. This serotype has also been rec-
ognized as an emerging cause of infection in other
countries in the world [29].
Increasing antimicrobial resistance was observed in
this study, especially to the conventional first-line
agents, such as β-lactam antibiotics and quinolones.
Regionally, NTS isolates recovered in Malaysia also
showed high resistance rates to tetracycline (70%), sul-
fonamides (57%), and streptomycin (53%) but lower
rates to ampicillin (30%),nalidicix acid (28%) and chlor-
amphenicol (21%) than in China [30]. Resistance rates in
the United States to ampicillin, chloramphenicol, and nali-
dixicacid were even lower, 20%, 11%, and 2.7%, respect-
ively [31]. Drug resistance in China is likely multifaceted,
with resistant isolates selected after environmental, clinical
and veterinary antibiotic exposures. Further investigations
exploring the emergence of resistant NTS isolates are re-
quired to control this public health problem.
Extended-spectrum cephalosporins and fluoroquino-
lones have been recommended for treatment of diarrhea
resulting from a NTS infection [32,33], although a re-
cent review suggests that there is little added benefit for
treatment in an otherwise healthy individual [33]. It is
noted that the prevalence of cephalosporins resistance
was higher in children aged <5 years than in patientsaged ≥5 years. Also the majority of isolates resistant to
all three cephalosporins were from children aged
<5 years, suggesting more attention should be given to
the severe resistance of Salmonella infections in young
children. High resistance will increase the diarrhea burden
among children [34]. In the United States, 4.1% of the iso-
lates displayed decreased susceptibility to either ceftriax-
one or ceftiofur in 2005 and 2006, while it was only 1% in
1996-1998 [9]. An increase in the number of isolates dis-
playing decreased susceptibility may have an impact on
clinical treatment and may lead to treatment failure as
cephalosporins are the primary choice for children.
Reduced susceptibility to ciprofloxacin is a current
trend in NTS isolates globally. The MIC of NTS isolates
from Asian countries rose from 0.125 to 1 μg/ml during
2003 to 2005 [12]. Nalidixic acid susceptibility testing
has been recommended by CLSI before using ciprofloxa-
cin for treatment, as isolates resistant to nalidixic acid
are probably resistant to ciprofloxacin [35].
This study had some limitations. First, selection of the
sentinel hospitals was based on convenience but not the
catchment size of the local population. Ten of the 28
hospitals involved were located in the capital city,
Guangzhou, while only two or three hospitals included
from the other cities in Guangdong. Future expansion of
NTS surveillance in Guangdong should incorporate hos-
pitals based on the coverage of the population in each
catchment area. Second, only a minority of all patients
with diarrhea have stool specimens collected for culture,
as stool culture is not required in China for diarrheal pa-
tients. Finally, the Salmonella isolation rate was not very
high, possibly because of previous antibiotic use or
laboratory testing sensitivity. In the future, increasing
the rate of specimen collection, the rate of isolation, the
number of facilities in surveillance, and improving the
representativeness of the surveillance system will help to
improve our understanding of foodborne disease inci-
dence and increase sensitivity for outbreak detection in
Guangdong China.
Conclusion
In conclusion, S. Typhimurium represented the most
common serotype followed by serotype 4,5,12:i:- in
Guangdong Province in China. Children aged <5 years
were the group most affected by Salmonella in
Guangdong Province. A high prevalence of antimicrobial
resistance, including resistance to ciprofloxacin and cepha-
losporins, was observed among the isolates, especially
from children aged <5 years. Improved characterization of
Salmonella infections would facilitate risk assessment of
Salmonella infections. Moreover, making the antimicrobial
susceptibility testing of Salmonella isolates by clinical la-
boratories routinely would allow clinicians to choose ap-
propriate antimicrobials for treatment of infectious
Liang et al. BMC Infectious Diseases  (2015) 15:53 Page 8 of 9diarrhea. However, additional data and more refined
methods can improve future surveillance. The invasive
Salmonella isolates should also be included to the antibiotic
resistance surveillance for clinical care or public health.
Limitation
It was a limitation that this study only included isolates
from stool but not from blood and etc. Due to the statis-
tic we have collected, we only can provide clinical corre-
lates with these isolates about whether the cases are
outpatients or inpatients. Since Fluoroquinolones are
commonly used to treat serious diarrheal for adults
while cephalosporins are often employed for children in
China, we compared the resistance of cefepime, nalidixic
acid, ciprofloxacin in inpatient cases is more severe than
in outpatient cases (P < 0.01), respectively. If we assumed
inpatient cases are more severe than outpatient cases, it
seems like the high antibiotic resistance prevalence is asso-
ciated with serious clinical diseases. However, more infor-
mation should be collected and analyzed in the future.
Consent
Written informed consent was obtained from the pa-
tient’s guardian/parent/next of kin for the publication of
this report and any accompanying images.
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